Figure 4
Number of adherent platelets/mm2 of vessel surface at baseline and during reperfusion in the group treated with saline (I/R) and those treated with abiciximab (AB), eptifibatide (EF), t-PA (tPA) and abiciximab plus t-PA (tAB) or eptifibatide plus t-PA (tEF), respectively. See text for details. Values are means ± SD, n = 35 experimental observations for each entry, *p < 0.05 vs. baseline; °p < 0.05 vs. I/R and tPA.